Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 427560, 14 pages
http://dx.doi.org/10.1155/2014/427560
Research Article

A Novel Contrast-Induced Acute Kidney Injury Model Based on the 5/6-Nephrectomy Rat and Nephrotoxicological Evaluation of Iohexol and Iodixanol In Vivo

1Division of Nephrology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
2Division of Nephrology, The Affiliated Changzhou No. 2 Hospital of Nanjing Medical College, Changzhou, Jiangsu 213003, China
3Shanghai Institute of Kidney and Dialysis, Shanghai 200032, China

Received 31 July 2014; Revised 6 October 2014; Accepted 14 October 2014; Published 11 November 2014

Academic Editor: Sidhartha D. Ray

Copyright © 2014 Tong-qiang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Seeliger, M. Sendeski, C. S. Rihal, and P. B. Persson, “Contrast-induced kidney injury: mechanisms, risk factors, and prevention,” European Heart Journal, vol. 33, no. 16, pp. 2007–2015, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Kodama, H. Watanabe, R. Tanaka et al., “A human serum albumin-thioredoxin fusion protein prevents experimental contrast-induced nephropathy,” Kidney International, vol. 83, no. 3, pp. 446–454, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. L. Jorgensen, “Contrast-induced nephropathy: pathophysiology and preventive strategies,” Critical Care Nurse, vol. 33, no. 1, pp. 37–46, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Guastoni, N. Bellotti, F. Poletti et al., “Continuous venovenous hemofiltration after coronary procedures for the prevention of contrast-induced acute kidney injury in patients with severe chronic renal failure,” The American Journal of Cardiology, vol. 113, no. 4, pp. 588–592, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. C. G. Duarte, J. Zhang, and S. Ellis, “The SHR as a small animal model for radiocontrast renal failure. Relation of nephrotoxicity to animal's age, gender, strain, and dose of radiocontrast,” Renal Failure, vol. 19, no. 6, pp. 723–743, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Ari, Y. Yilmaz, A. E. Kedrah et al., “Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy,” American Journal of Nephrology, vol. 33, no. 3, pp. 269–276, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Ozkan, S. Ulusoy, A. Orem et al., “Protective effect of the grape seed proanthocyanidin extract in a rat model of contrast-induced nephropathy,” Kidney and Blood Pressure Research, vol. 35, no. 6, pp. 445–453, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Efrati, S. Berman, I. Ilgiyeav, Y. Siman-Tov, Z. Averbukh, and J. Weissgarten, “Differential effects of N-acetylcysteine, theophylline or bicarbonate on contrast-induced rat renal vasoconstriction,” The American Journal of Nephrology, vol. 29, no. 3, pp. 181–191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. C. T. Wu, T. I. Weng, L. P. Chen, C. K. Chiang, and S. H. Liu, “Involvement of caspase-12-dependent apoptotic pathway in ionic radiocontrast urografin-induced renal tubular cell injury,” Toxicology and Applied Pharmacology, vol. 266, no. 1, pp. 167–175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Sun, T. Zhang, P. Nie et al., “A novel rat model of contrast-induced acute kidney injury,” International Journal of Cardiology, vol. 172, no. 1, pp. e48–e50, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Jensen, R. W. Doughty, D. Grant, and O. Myhre, “A modified model of gentamicin induced renal failure in rats: toxicological effects of the iodinated X-ray contrast media ioversol and potential usefulness for toxicological evaluation of iodinated X-ray contrast media,” Experimental and Toxicologic Pathology, vol. 65, no. 5, pp. 601–607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Ackland, “Prevalence, detection, evaluation and management of chronic kidney disease,” British Medical Journal, vol. 348, 2014. View at Publisher · View at Google Scholar
  13. L. Zhang, F. Wang, L. Wang et al., “Prevalence of chronic kidney disease in China: a cross-sectional survey,” The Lancet, vol. 379, no. 9818, pp. 815–822, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. K. A. Griffin, A. K. Bidani, J. Ouyang, V. Ellis, M. Churchill, and P. C. Churchill, “Role of endothelium-derived nitric oxide in hemodynamic adaptations after graded renal mass reduction,” American Journal of Physiology, vol. 264, no. 6, part 2, pp. R1254–R1259, 1993. View at Google Scholar · View at Scopus
  15. K. A. Griffin, M. Picken, and A. K. Bidani, “Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury,” Journal of the American Society of Nephrology, vol. 4, no. 12, pp. 2023–2031, 1994. View at Google Scholar · View at Scopus
  16. L. C. Racusen and K. Solez, “Nephrotoxic tubular and interstitial lesions: morphology and classification,” Toxicologic Pathology, vol. 14, no. 1, pp. 45–57, 1986. View at Publisher · View at Google Scholar · View at Scopus
  17. J.-M. Idée and B. Bonnemain, “Reliability of experimental models of iodinated contrast media-induced acute renal failure: From methodological considerations to pathophysiology,” Investigative Radiology, vol. 31, no. 4, pp. 230–241, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Ware, P. Brodsky, A. A. Satoskar et al., “Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation,” Journal of the American Society of Nephrology, vol. 22, no. 10, pp. 1856–1862, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Jiang and M. Wang, “Hyperphosphatemia-induced hyperparathyroidism in 5/6 nephrectomized rats: development of a new animal model,” Chinese Medical Journal, vol. 121, no. 23, pp. 2440–2443, 2008. View at Google Scholar · View at Scopus
  20. N. Fukunaga, N. Takahashi, S. Hagiwara et al., “Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress,” Heart Rhythm, vol. 9, no. 12, pp. 2023–2031, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Krause, “In vitro and animal experiments in contrast media testing,” Investigative Radiology, vol. 33, no. 3, pp. 182–191, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Solez, L. C. Racusen, and S. Olsen, “The pathology of drug nephrotoxicity,” The Journal of Clinical Pharmacology, vol. 23, no. 10, pp. 484–490, 1983. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Jost, P. Lengsfeld, D. C. Lenhard, H. Pietsch, J. Hütter, and M. A. Sieber, “Viscosity of iodinated contrast agents during renal excretion,” European Journal of Radiology, vol. 80, no. 2, pp. 373–377, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Seeliger, B. Flemming, T. Wronski et al., “Viscosity of contrast media perturbs renal hemodynamics,” Journal of the American Society of Nephrology, vol. 18, no. 11, pp. 2912–2920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Solomon, “Contrast media: are there differences in nephrotoxicity among contrast media?” BioMed Research International, vol. 2014, Article ID 934947, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Palm, P.-O. Carlsson, A. Fasching et al., “Effects of the contrast medium iopromide on renal hemodynamics and oxygen tension in the diabetic rat kidney,” Advances in Experimental Medicine and Biology, vol. 530, pp. 653–659, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Seeliger, K. Cantow, K. Arakelyan, M. Ladwig, P. B. Persson, and B. Flemming, “Low-dose nitrite alleviates early effects of an X-ray contrast medium on renal hemodynamics and oxygenation in rats,” Investigative Radiology, vol. 49, no. 2, pp. 70–77, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. P. C. Y. Wong, Z. Li, J. Guo, and A. Zhang, “Pathophysiology of contrast-induced nephropathy,” International Journal of Cardiology, vol. 158, no. 2, pp. 186–192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Jensen, R. W. Doughty, D. Grant, and O. Myhre, “The effects of the iodinated X-ray contrast media iodixanol, iohexol, iopromide, and ioversol on the rat kidney epithelial cell line NRK 52-E,” Renal Failure, vol. 33, no. 4, pp. 426–433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Aspelin, P. Aubry, S.-G. Fransson, R. Strasser, R. Willenbrock, and K. J. Berg, “Nephrotoxic effects in high-risk patients undergoing angiography,” The New England Journal of Medicine, vol. 348, no. 6, pp. 491–499, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. M. C. Heinrich, L. Häberle, V. Müller, W. Bautz, and M. Uder, “Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials,” Radiology, vol. 250, no. 1, pp. 68–86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. B. J. Barrett, R. W. Katzberg, H. S. Thomsen et al., “Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol,” Investigative Radiology, vol. 41, no. 11, pp. 815–821, 2006. View at Publisher · View at Google Scholar · View at Scopus